Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Symptom |hepatitis c
Sentences 114
PubMedID- 21129375 Background & aims: interferon reportedly decreases the incidence of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 24462733 A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis.
PubMedID- 21537363 A 78-year-old male who experienced multiple recurrences of hepatocellular carcinoma (hcc) with hepatitis c virus (hcv)-related cirrhosis underwent transcatheter arterial chemoembolization and ablation and survived for more than 10 years.
PubMedID- 22207106 Randomized controlled trials also confirm that glycyrrhizin and its derivatives can improve the hepatocellular injury in chronic hepatitis b or c patients, and reduce the risk for hepatocellular carcinoma in patients with hepatitis c virus-induced cirrhosis .
PubMedID- 21619694 Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma , suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor.
PubMedID- 22957141 End-stage liver diseases as well as hepatocellular carcinoma attributable to chronic hepatitis c are increasingly serious problems2.
PubMedID- 21056500 Background & aims: evidence on the efficacy of antiviral treatment in chronic hepatitis c (chc) patients with hepatocellular carcinoma (hcc) after curative treatment is scarce.
PubMedID- 21766498 Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection.
PubMedID- 22919246 A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis c virus patients with hepatocellular carcinoma.
PubMedID- 26017875 Alterations of wnt/beta-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis c virus.
PubMedID- 24843320 Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection.
PubMedID- 26045707 Sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c. advanced liver fibrosis is still a risk factor for the incidence of hepatocellular carcinoma, in spite of hepatitis c patients attained a sustained virological response.
PubMedID- 25373121 Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis c.
PubMedID- 22743730 Case report: a 60 year-old man underwent ldlt for hepatitis c virus-related cirrhosis with hepatocellular carcinoma.
PubMedID- 22911171 Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included.
PubMedID- 20458764 Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c.
PubMedID- 23509319 Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 23099187 Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study.
PubMedID- 23125843 The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005).
PubMedID- 23065464 Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects.
PubMedID- 21563203 Inactivation of klf6 is common in hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection, thereby abrogating its normal antiproliferative activity in liver cells.
PubMedID- 21820396 Background & aims: hepatocellular carcinoma (hcc) can result from hepatitis c virus (hcv)-related liver disease and is the fastest-growing cause of cancer-related death in the united states.
PubMedID- 22555181 Background: the extent of the effect of antiviral therapy and its predictors in preventing hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c (chc) or b (chb) remain unclear.
PubMedID- 21374690 Previous studies have suggested that prior exposure to hepatitis b virus (hbv) infection may increase the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 25559606 The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection.
PubMedID- 26305067 A variant in pnpla3 associated with fibrosis progression but not hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 24223741 Purpose: recent studies have revealed that branched-chain amino acids (bcaa) reduce the development of hepatocellular carcinoma (hcc) in patients with obesity and hepatitis c virus infection by improving insulin resistance (ir).
PubMedID- 22004425 Genetic risk of hepatocellular carcinoma in patients with hepatitis c virus: a case control study.
PubMedID- 21331763 Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 22363173 We observed a strong correlation between hepatic 8-oxodg staining and serum ferritin levels, suggesting the iron content to be a strong mediator of oxidative stress and iron reduction to reduce the incidence of hepatocellular carcinoma in patients with chronic hepatitis c .
PubMedID- 25788045 Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment.
PubMedID- 23689989 Il28b minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis c virus infection.
PubMedID- 23404391 Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis c: report of a case.
PubMedID- 26519622 The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis c virus-related cirrhosis.
PubMedID- 22212964 Viral hepatitis among somali immigrants in minnesota: association of hepatitis c with hepatocellular carcinoma.
PubMedID- 21253791 Overall, these data suggest that chemoprevention of hepatocellular carcinoma in patients with chronic hepatitis c is an achievable objective.
PubMedID- 21133598 Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection.
PubMedID- 25331666 Increased risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 25657603 In a recent report from our institution, we identified over a three-year period 3% (9/298) of ltx patients who developed severe hf after ltx.62 in these nine patients, etiology of liver failure was hepatitis c with hepatocellular carcinoma in four, hemochromatosis in four (with one showing evidence of iron deposition in the heart on biopsy), and one with primary biliary cirrhosis.
PubMedID- 20087166 hepatitis c prevalence in patients with hepatocellular carcinoma without cirrhosis.
PubMedID- 24037287 In fact, diverse studies have already correlated viral exposure to epigenetic alterations and human cancer such as hepatitis b virus and hepatitis c virus with hepatocellular carcinoma1626.
PubMedID- 25667487 Patients and methods: serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis c virus infection who underwent curative hepatectomy.
PubMedID- 20521755 The american association for the study of liver diseases recommends ultrasound surveillance for hepatocellular carcinoma in persons with chronic hepatitis c virus infection and cirrhosis.
PubMedID- 23463401 hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region.
PubMedID- 22899800 A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis c after sustained response to pegylated interferon and ribavirin combination therapy.
PubMedID- 20731020 hepatocellular carcinoma in patients with chronic hepatitis c virus infection without cirrhosis.
PubMedID- 24367218 Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus.
PubMedID- 23547582 Screening for hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 26191473 In addition, dm has been suggested to enhance the development of hepatocellular carcinoma in patients with chronic hepatitis c (kawamura et al.
PubMedID- 23267897 A 76-year-old man, who had been treated with interferon-alpha(ifn-alpha) for hepatitis c, was diagnosed with multiple hepatocellular carcinomas (hcc; s7/8, s8, s5, s2) with right hepatic vein tumor thrombus (vv2).

Page: 1 2 3